Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption

Cancer Discovery(2025)10.1158/2159-8290.cd-25-0247Source: DataRank Database

Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption is a research paper published in Cancer Discovery (2025). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 5.16)OA: hybridTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Madison Nguyen ORCID,Drew N. Wilfahrt ORCID,Zakaria Larbi Dahmani ORCID,Ansen B.P. Burr ORCID,Bingxian Xie ORCID

Live enrichment

PubMed:40742298 PMC:PMC12580791 OpenAlex:https://openalex.org/W4412790284

Damon Runyon Cancer Research Foundation

Grant: Dale F. Frey Breakthrough Scientist Award

Gateway Foundation

Grant: G-22-800

National Institutes of Health

Grant: P30CA047904

National Institutes of Health

Grant: DP2AI177967

National Institutes of Health

Grant: S10OD023402

National Institutes of Health

Grant: S10OD032141

National Institutes of Health

Grant: R01CA206517

National Institutes of Health

Grant: T32GM008208

National Institutes of Health

Grant: U01 CA271407

National Institutes of Health

Grant: R01 CA257265

National Institutes of Health

Grant: U01 CA268806

National Institutes of Health

Grant: P50 CA254865

NIAID NIH HHS

Grant: R01 AI166598

NIAID NIH HHS

Grant: R01 AI138504

FWCI

5.16

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-25-0247/3634052/cd-25-0247.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-25-0247/3634052/cd-25-0247.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-25-0247/3657069/cd-25-0247.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/15/11/2278/3664673/cd-25-0247.pdf

journalhttps://doi.org/10.1158/2159-8290.cd-25-0247

Fields of Study

Gut microbiota and healthCancer Immunotherapy and BiomarkersBiochemical Analysis and Sensing Techniques

MeSH Terms

Gastrointestinal MicrobiomeImmune Checkpoint InhibitorsAnimalsFemaleHumansImmunotherapyMice, Inbred C57BLNeoplasmsSucroseSweetening AgentsMice

Keywords

SucraloseMicrobiomeImmune systemImmunotherapyCancerCancer immunotherapyGut floraBiologyImmunologyCancer researchBioinformaticsFood scienceGenetics

Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption

FAIR Checklist

Authors (20)

Funding (14 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)